NEI Welcomes New Council Members
The National Eye Institute recently appointed two new members to its National Advisory Eye Council. (Source: News from NEI)
Source: News from NEI - June 30, 2014 Category: Opthalmology Source Type: news

Soothing cells, peaceful protein could hold promise for treating autoimmune uveitis
Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss. (Source: News from NEI)
Source: News from NEI - June 30, 2014 Category: Opthalmology Source Type: news

Telemedicine catches blinding disease in premature babies
Telemedicine is an effective strategy to screen for the potentially blinding disease known as retinopathy of prematurity (ROP), according to a study funded by the National Eye Institute (NEI). The investigators say that the approach, if adopted broadly, could help ease the strain on hospitals with limited access to ophthalmologists and lead to better care for infants in underserved areas of the country. NEI is a part of the National Institutes of Health (Source: News from NEI)
Source: News from NEI - June 26, 2014 Category: Opthalmology Source Type: news

Making artificial vision look more natural
In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object. Although more work remains, this is a step toward restoring natural, high-fidelity vision to blind people, the researchers say. The work was funded in part by the National Institutes of Health. (Source: News from NEI)
Source: News from NEI - June 5, 2014 Category: Opthalmology Source Type: news

New research sheds light on how UV rays may contribute to cataract
A new study offers an explanation for how years of chronic sunlight exposure can increase the risk of cataract, a clouding of the eye lens that typically occurs with aging. The study firms up a link between the sun's damaging rays and a process called oxidative stress. It was funded in part by the National Eye Institute (NEI). (Source: News from NEI)
Source: News from NEI - June 3, 2014 Category: Opthalmology Source Type: news

NEI's Ferris and Chew receive Helen Keller Prize for Vision Research
Frederick L. Ferris III, M.D., and Emily Y. Chew, M.D., who are director and deputy director of the NEI Division of Epidemiology and Clinical Applications, have received the Helen Keller Prize for Vision Research. (Source: News from NEI)
Source: News from NEI - May 13, 2014 Category: Opthalmology Source Type: news

NEI announces funding for new imaging technology to support Audacious Goal
The National Eye Institute has announced a funding opportunity for imaging cells and tissues of the visual system. The announcement (RFA-EY-14-001) is the first in support of the primary goal of the NEI Audacious Goal Initiative (AGI): to regenerate neurons and neural connections in the eye and visual system. (Source: News from NEI)
Source: News from NEI - April 30, 2014 Category: Opthalmology Source Type: news

Glaucoma drug helps women with blinding disorder linked to obesity
An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health. (Source: News from NEI)
Source: News from NEI - April 22, 2014 Category: Opthalmology Source Type: news

Seto Named NEI Deputy Director
Dr. Belinda Seto joined the National Eye Institute (NEI) as its deputy director on April 7, 2014. She comes to NEI from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), where she served as deputy director for 11 years, starting just three years after NIBIB was established. (Source: News from NEI)
Source: News from NEI - April 17, 2014 Category: Opthalmology Source Type: news

Within sight: Light-activated drugs for restoring vision
Researchers have made progress toward an approach that would use light-sensitive drugs to stimulate cells in the retina and restore vision to people who are blind or visually impaired. (Source: News from NEI)
Source: News from NEI - March 19, 2014 Category: Opthalmology Source Type: news

NEI's Brooks elected to elite physician-scientist organization
Dr. Brian Brooks of NEI has been elected into one of the nation's most respected medical honor societies, the American Society for Clinical Investigation (ASCI). The society publishes the Journal of Clinical Investigation, and elects the journal's editor-in-chief from its ranks. (Source: News from NEI)
Source: News from NEI - March 19, 2014 Category: Opthalmology Source Type: news

Contacts better than permanent lenses for babies after cataract surgery
For adults and children who undergo cataract surgery, implantation of an artificial lens is the standard of care. But a clinical trial suggests that for most infants, surgery followed by the use of contact lenses for several years—and an eventual lens implant—may be the better solution. The trial was funded in part by the National Eye Institute (NEI), a component of the National Institutes of Health. (Source: News from NEI)
Source: News from NEI - March 6, 2014 Category: Opthalmology Source Type: news

NEI Pays Tribute to Founding Father Jules Stein
The National Eye Institute paid tribute to the late Dr. Jules Stein on Jan. 7, 2014. After making millions in show business, Stein spearheaded a campaign that convinced Congress to establish NEI in 1968. (Source: News from NEI)
Source: News from NEI - February 24, 2014 Category: Opthalmology Source Type: news

An Experimental Contact Lens to Prevent Glaucoma-Induced Blindness
Like a miniature donut stuffed inside a tiny pita pocket, a common glaucoma medicine is sandwiched inside this specially designed contact lens. In laboratory experiments, the lens, which can also correct vision, releases the eyesight-saving medication at a steady rate for up to a month. Its construction offers numerous potential clinical advantages over the standard glaucoma treatment and may have additional applications, such as delivering anti-inflammatory drugs or antibiotics to the eye. (Source: News from NEI)
Source: News from NEI - February 3, 2014 Category: Opthalmology Source Type: news

Translational research through teamwork: NEI program aims to accelerate new therapies for blinding diseases
Imagine you are building a house. You would need a team of specialists, including an architect, a general contractor, carpenters, an electrician, a plumber and many others. Now picture yourself leading an effort to develop a new therapeutic drug or device. For that, you'd need a very different kind of specialized team. (Source: News from NEI)
Source: News from NEI - January 8, 2014 Category: Opthalmology Source Type: news